Keck School of Medicine, University of Southern California

Michael Rafii is Professor of Neurology at the Keck School of Medicine and Medical Director of the Alzheimer’s Therapeutic Research Institute (ATRI) and directs the Medical Safety unit for the Alzheimer's Clinical Trials Consortium (ACTC). He is co-PI of the Alzheimer’s Network for Treatment and Diagnostics (ALZ-NET) and Principal Investigator of the NIH-funded Alzheimer’s Clinical Trials Consortium - Down Syndrome (ACTC-DS), an international network of academic researchers with expertise in AD and DS.